TP53 and cancer: In addition, p53 antibodies are not restricted to a single cancer type [23] and the observation that anti-p53 antibodies are detectable in subgroups of patients with inflammatory diseases who never develop a malignancy represents another important downside of the use of p53 serology for diagnostic purposes.